The drugmaking unit of South Korea’s Lotte Group is betting on growth from a global shift in pharmaceutical production away from Chinese players amid rising geopolitical tension and tariff ...

Dr. Garth Graham brings an unparalleled pedigree to the stage. In addition to his experience at Google and YouTube, Graham served as U.S. Deputy Assistant Secretary for Health under two ...

Speaker submissions are officially open for NextGen 2026 as the practitioner-first conference seeks end-user leaders with implementation-driven case studies across logistics, retail, food & beverage, ...

Management's guidance language shifted from a general $4 billion revenue target by 2027 in Q3 to a more aggressive "double down" commitment to reaching the run rate by the end of 2026, not requiring ...

Pharmacy leaders sound alarm on workforce crisis as shortages of pharmacists and technicians threaten health systems in 2026 and beyond.

In today’s Pharma Pulse, the FDA unveils a Plausible Mechanism framework to fast-track ultra-rare disease therapies, while ...

AI advances and new data on genomics, patient outcomes, and drug performance have pushed the idea of “digital twins” closer to reality than ever before.

In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...

Tarsus Pharmaceuticals remains a Strong Buy, driven by Xdemvy's robust growth and management's $2B+ peak sales target. Click ...

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap ...

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...

New Senior-Level Insights Provide a Strategic Roadmap for Navigating Trends, Technology, and Trust in a Rapidly Shifting Pharma Media ...